Samsung Research America's Digital Health Team unveiled two artificial intelligence foundation models engineered to process and extract insights from wearable biosignal data. The models leverage smartwatch information including heart rate variability, sleep patterns, and movement metrics to predict health outcomes and detect physiological anomalies.
The announcement came during Samsung's Health Forum presentation at Galaxy Unpacked in July 2026, where the company outlined its Connected Care vision. This initiative represents a shift toward using wearables as primary health monitoring devices rather than simple activity trackers.
Foundation models operate differently from conventional machine learning systems. Rather than requiring task-specific training for each health metric, foundation models learn broad patterns from large datasets and adapt to downstream applications. Samsung's approach allows the models to recognize correlations between multiple biosignals simultaneously. A single smartwatch generates continuous streams of heart rate, electrocardiogram patterns, respiration data, and movement information. Traditional systems analyze these in isolation. Samsung's models cross-reference these signals to identify subtle health changes that isolated metrics miss.
The company targets real-world clinical applications. Heart arrhythmia detection represents one early use case. The models can flag irregular rhythms before users experience symptoms. Sleep quality assessment stands as another application. Rather than simply counting hours asleep, the AI distinguishes between light, deep, and REM sleep stages, correlating sleep quality with daytime performance and long-term health risks.
Samsung's Connected Care ecosystem positions wearables as entry points into broader health services. Users receive actionable insights directly from their devices. Integration with Samsung's healthcare partnerships potentially connects users to medical professionals when the AI identifies concerning patterns. This closes the loop between detection and intervention, addressing a historical gap where wearables generated data but lacked clinical pathways for abnormal readings.
Data privacy shapes the technical architecture. Samsung emphasizes on-device processing where possible, reducing reliance on cloud servers to store sensitive health information. Edge computing keeps biosignal data local while still leveraging the foundation models' analytical capabilities.
Competition in wearable health AI intensifies. Apple Health has integrated ECG and fall detection into its watches. Fitbit uses machine learning for atrial fibrillation screening. Google's acquisition of Fitbit signals broader investment in health AI. Samsung's foundation model approach offers potential scalability advantages. A single model can power multiple health applications, reducing development time and computational overhead compared to training separate models for each condition.
The technology's clinical validity remains an open question. Foundation models require rigorous validation against established diagnostic standards. FDA approval processes will determine which applications qualify as medical devices versus consumer wellness tools. Samsung likely pursues regulatory pathways for its most mature applications while positioning others as research or consumer features.
The timing reflects broader trends. Wearable adoption continues climbing. Medical professionals increasingly trust smartwatch data for preliminary screening. Regulatory bodies work to establish standards for wearable-based diagnostics. Samsung's foundation models arrive as the ecosystem matures, positioning the company to capture market share in health AI infrastructure.